Suppr超能文献

丝氨酸 31 号酪氨酸羟化酶磷酸化与 6-OHDA 损伤后黑质纹状体通路多巴胺恢复的差异平行。

ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

机构信息

Department of Pharmacology, Toxicology& Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.

出版信息

J Neurochem. 2014 May;129(3):548-58. doi: 10.1111/jnc.12652. Epub 2014 Jan 27.

Abstract

Compensatory mechanisms in dopamine (DA) signaling have long been proposed to delay onset of locomotor symptoms during Parkinson's disease progression until ~ 80% loss of striatal DA occurs. Increased striatal dopamine turnover has been proposed to be a part of this compensatory response, but may occur after locomotor symptoms. Increased tyrosine hydroxylase (TH) activity has also been proposed as a mechanism, but the impact of TH protein loss upon site-specific TH phosphorylation in conjunction with the impact on DA tissue content is not known. The tissue content of DA was determined against TH protein loss in the striatum and substantia nigra (SN) following 6-hydroxydopamine lesion in the medial forebrain bundle in young Sprague-Dawley male rats. Although DA predictably decreased in both regions following 6-hydroxydopamine, there was a significant difference in DA loss between the striatum (75%) and SN (40%), despite similar TH protein loss. Paradoxically, there was a significant decrease in DA against remaining TH protein in striatum, but a significant increase in DA against remaining TH in SN. In the SN, increased DA per remaining TH protein was matched by increased ser31, but not ser40, TH phosphorylation. In striatum, both ser31 and ser40 phosphorylation decreased, reflecting decreased DA per TH. However, in control nigral and striatal tissue, only ser31 phosphorylation correlated with DA per TH protein. Combined, these results suggest that the phosphorylation of ser31 in the SN may be a mechanism to increase DA biosynthesis against TH protein loss in an in vivo model of Parkinson's disease. Properties of dopamine biosynthesis were evaluated in the 6-OHDA model of Parkinson's disease by studying the impact of tyrosine hydroxylase (TH) protein loss on its own phosphorylation and dopamine (DA) tissue content in rat nigrostriatal pathway. A dichotomous response was observed between striatum and substantia nigra in that dopamine per remaining TH decreased in striatum, but increased in substantia nigra. Phosphorylation at ser31 reflected these differences, indicating that ser31 phosphorylation may be critical to maintain dopamine with progressive TH protein loss. Drawings are from slides purchased from Motifolio (http://motifolio.com/).

摘要

多巴胺(DA)信号的补偿机制长期以来一直被认为可以延迟帕金森病进展过程中运动症状的发作,直到纹状体 DA 丢失达到约 80%。纹状体多巴胺周转率的增加被认为是这种补偿反应的一部分,但可能发生在运动症状之后。酪氨酸羟化酶(TH)活性的增加也被认为是一种机制,但 TH 蛋白丢失对特定部位 TH 磷酸化的影响以及对 DA 组织含量的影响尚不清楚。在年轻的 Sprague-Dawley 雄性大鼠中,通过内侧前脑束中的 6-羟多巴胺损伤,测定了纹状体和黑质(SN)中 TH 蛋白丢失后 DA 的组织含量。尽管 6-羟多巴胺后两个区域的 DA 都可预测性地降低,但纹状体(75%)和 SN(40%)之间的 DA 丢失存在显著差异,尽管 TH 蛋白丢失相似。矛盾的是,尽管纹状体中剩余 TH 蛋白的 DA 显著减少,但 SN 中剩余 TH 蛋白的 DA 却显著增加。在 SN 中,剩余 TH 蛋白中 DA 的增加与 ser31 的增加相匹配,但与 ser40 的增加不匹配。在纹状体中,ser31 和 ser40 磷酸化均降低,反映出 DA 与 TH 比值降低。然而,在对照的黑质和纹状体组织中,只有 ser31 磷酸化与 TH 蛋白的 DA 相关。综合来看,这些结果表明,在帕金森病的体内模型中,SN 中 ser31 的磷酸化可能是一种增加 DA 生物合成以对抗 TH 蛋白丢失的机制。通过研究酪氨酸羟化酶(TH)蛋白丢失对其自身磷酸化和大鼠黑质纹状体通路中多巴胺(DA)组织含量的影响,评估了 6-OHDA 帕金森病模型中多巴胺生物合成的特性。纹状体和 SN 之间观察到二分法反应,即纹状体中剩余 TH 的多巴胺减少,但 SN 中增加。ser31 的磷酸化反映了这些差异,表明 ser31 磷酸化对于维持多巴胺与进行性 TH 蛋白丢失至关重要。幻灯片购自 Motifolio(http://motifolio.com/)。

相似文献

2
Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.
Neurotoxicology. 2018 Jul;67:121-128. doi: 10.1016/j.neuro.2018.05.003. Epub 2018 May 18.
10
Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.
ACS Chem Neurosci. 2016 Jul 20;7(7):941-51. doi: 10.1021/acschemneuro.6b00064. Epub 2016 May 10.

引用本文的文献

1
Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice.
NPJ Parkinsons Dis. 2025 May 30;11(1):143. doi: 10.1038/s41531-025-00991-4.
9
Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease.
ACS Pharmacol Transl Sci. 2021 Mar 16;4(2):858-869. doi: 10.1021/acsptsci.1c00013. eCollection 2021 Apr 9.

本文引用的文献

1
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.
Mol Neurobiol. 2014 Jun;49(3):1282-92. doi: 10.1007/s12035-013-8598-0. Epub 2013 Dec 3.
3
5
Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
PLoS One. 2012;7(12):e52322. doi: 10.1371/journal.pone.0052322. Epub 2012 Dec 26.
8
Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.
Brain. 2012 Jul;135(Pt 7):2058-73. doi: 10.1093/brain/aws133. Epub 2012 Jun 19.
10
Ciliary neurotrophic factor stimulates tyrosine hydroxylase activity.
J Neurochem. 2012 Jun;121(5):700-4. doi: 10.1111/j.1471-4159.2012.07712.x. Epub 2012 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验